PREVIFENON Trademark

Trademark Overview


On Wednesday, July 1, 2020, a trademark application was filed for PREVIFENON with the United States Patent and Trademark Office. The USPTO has given the PREVIFENON trademark a serial number of 90031217. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 18, 2022. This trademark is owned by MELISA Institute Genomics & Proteomics Research SpA. The PREVIFENON trademark is filed in the Pharmaceutical Products category with the following description:

Contrast media for in vivo imaging; Sanitary panties; Pharmaceutical preparations for treating and prevention of respiratory diseases and disorders; Pharmaceutical preparations for the treatment and prevention of viral respiratory infectious diseases; Pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria, namely, antibiotics; Pharmaceutical preparations for the prevention of diseases of the respiratory system; Pharmaceutical preparations for the prevention of diseases and disorders of the immune system; Pharmaceutical products for the prevention and treatment of cognitive and intellectual deficit disorders, delays in psychomotor neurodevelopment, gestational disorders, hypertension, viral infections, sexually transmitted diseases, diseases caused by fungal infections, neoplasms and cancer
previfenon

General Information


Serial Number90031217
Word MarkPREVIFENON
Filing DateWednesday, July 1, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 18, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 20, 2021

Trademark Statements


Goods and ServicesContrast media for in vivo imaging; Sanitary panties; Pharmaceutical preparations for treating and prevention of respiratory diseases and disorders; Pharmaceutical preparations for the treatment and prevention of viral respiratory infectious diseases; Pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria, namely, antibiotics; Pharmaceutical preparations for the prevention of diseases of the respiratory system; Pharmaceutical preparations for the prevention of diseases and disorders of the immune system; Pharmaceutical products for the prevention and treatment of cognitive and intellectual deficit disorders, delays in psychomotor neurodevelopment, gestational disorders, hypertension, viral infections, sexually transmitted diseases, diseases caused by fungal infections, neoplasms and cancer
Translation of Words in MarkThe wording ¿PREVIFENON¿ has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 29, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMELISA Institute Genomics & Proteomics Research SpA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressConcepcion CP4133515
CL

Party NameMELISA Institute Genomics & Proteomics Research SpA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressConcepcion CP4133515
CL

Trademark Events


Event DateEvent Description
Monday, July 18, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 18, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 7, 2021SOU EXTENSION 1 GRANTED
Tuesday, December 7, 2021SOU EXTENSION 1 FILED
Tuesday, December 7, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 15, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 20, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 31, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 16, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, March 16, 2021ASSIGNED TO LIE
Tuesday, March 16, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 16, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, March 16, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, March 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 15, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 6, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 6, 2020NON-FINAL ACTION E-MAILED
Tuesday, October 6, 2020NON-FINAL ACTION WRITTEN
Tuesday, October 6, 2020ASSIGNED TO EXAMINER
Wednesday, July 29, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 4, 2020NEW APPLICATION ENTERED